Allogeneic Stem Cell Therapy for Acute Ischemic Stroke
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Allogeneic Stem Cell Therapy for Acute Ischemic Stroke: The Phase 2/3 TREASURE Randomized Clinical Trial
JAMA Neurol 2024 Jan 16;[EPub Ahead of Print], K Houkin, T Osanai, S Uchiyama, K Minematsu, A Taguchi, K Maruichi, Y Niiya, K Asaoka, Y Kuga, K Takizawa, K Haraguchi, S Yoshimura, K Kimura, K Tokunaga, A Aoyama, F Ikawa, C Inenaga, T Abe, A Tominaga, S Takahashi, K Kudo, M Fujimura, T Sugiyama, M Ito, M Kawabori, DC Hess, SI Savitz, T HiranoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.